Australia’s Therapeutic Goods Administration (TGA) has reclassified two psychedelic substances to facilitate their use as medicines for certain mental...
This is the FDA’s first guidance focusing on psychedelic drug development. Phillips Lytle law firm takes a closer look. The post FDA Draft Guidance on...
Psychedelic stocks have a bright future with 13.5% compound annual growth expected through 2029. That growth will certainly draw in investment funding...
Legal psychedelic treatment doesn’t mean much if no one can afford it. The cost of psychedelic-assisted therapy is undoubtedly high, and ensuring equitable...
The U.S. Food and Drug Administration (FDA) has released a groundbreaking draft guidance to provide crucial insights for researchers exploring The post...
Public comment on the draft proposal will be collected for the next 60 days. The post FDA Issues Draft Guidance on Clinical Trials for Psychedelic Drugs...
Psychedelic Science 2023 wrapped up with lessons from drug policy activism, psychedelics and sex, wisdom from elders, and protestors speaking out against...
Psychedelic Science 2023 wrapped up with lessons from drug policy activism, psychedelics and sex, wisdom from elders, and protestors speaking out against...
image: MPH Photos/Shutterstock The best-known story of psychedelic use among professional athletes is the time in 1970 when the San Diego Padres’s Doc...
Psychedelic Science 2023 continues with MAPS’s funding announcement, Roland Griffith’s emotional lecture, and panel discussions on Buddhism, ketamine,...